chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Painful and swollen left knee; Painful and swollen left knee; Painful and swollen thigh after 24 hours after vaccination.; In left arm pain; little swollen in 5 hours after; This is a spontaneous report from a contactable consumer or other non hcp. A 72-year-old female patient received bnt162b2 (BNT162B2, solution for injection, Lot #: EN6201), dose 1 via an unspecified route of administration, administered in Arm Left on 12Feb2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On 12Feb2021, the patient experienced in left arm pain, little swollen in 5 hours after, On 13Feb2021, the patient experienced painful and swollen left knee, painful and swollen thigh after 24 hours after vaccination. The action taken in response to the event for bnt162b2 was not applicable. Therapeutic measures were taken as a result of in left arm pain (pain in extremity), little swollen in 5 hours after (peripheral swelling), painful and swollen left knee (arthralgia), painful and swollen left knee (joint swelling), painful and swollen thigh after 24 hours after vaccination. (pain in extremity). The outcome of the event was not recovered.
Dizziness, tingling, prickling, faint feeling, pins & needles, electrical shock sensations, numbness, fatigue, weakness, muscle cramps & jerks, muscle pain, buzzing, loss of balance, partial vision loss. Medications - Nortriptyline, NEURONTIN, PROAMATINE.
Hoarse voice, mild SOB, laryngitis Patient taken to the ED and given IV diphenhydramine
March 2021, a rash started on top of my feet. It was purple (not raised, did not itch, burn or hurt), but spread up the inside of both legs, inner thigh then bilateral flank, upper arm, wrist and top of hands. It was not on my abdomen, back or hips. I went to see a general practitioner, who treated me for contact dermatitis. I was told if not better in a week to go see a dermatologist. I went to a dermatology clinic where they did biopsies, which came back as granuloma annulare. This is a condition caused by an immune response to a vaccine.
Client c/o tingling of mouth and face.  No distress note at the moment.  Client able to voice concerns.  Client seen by EMT.  No v/s obtained.  Client instructed to contact PCP or go to ER if symptom worsen and cleared to go by EMT.
2 minutes after administering the vaccines the patient briefly passed out.  She was placed in a supine position and given some water.  Vital signs were taken, BP and Pulse remained normal.  Eventually patient was able to sit up and felt better.  Patient remained in the office for 25 minutes after the event, was released home with mom, instructed to avoid strenuous activities and swimming today.
Patient received pfizer vaccine on 1/21/21, 2/11/21, and 10/20/2021. Presented to ER on 7/18/22. COVID positive on 7/18/22.  came in with history of generalized weakness for the last 3-4 days.  Patient says he was tested positive for COVID-19 on Thursday last week.  Patient denies any cough or shortness of breath or wheezing.  Patient is not vaccinated for COVID-19.  Patient denies any fever or chills.  Patient has been falling for the in the last few days.  Patient denies any headache or nausea or vomiting.  Denies any chest pain or shortness of breath or palpitations.Patient least not hypoxic doing well on room air, will continue to monitor closely Mild drop in WBCs. DIscharged on 7/20/22
Administered havrix and infanrix after temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a female patient who received HAV (Havrix) (batch number 2K57N, expiry date 11th December 2022) for prophylaxis.   Co-suspect products included DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis and dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 21st February 2022, the patient received the 1st dose of Havrix, the 1st dose of Infanrix and Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix, Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Linked case(s) involving the same patient:  US2022093643   Additional Information: GSK Receipt Date: 15-JUN-2022 Reporter's Comment: Medical assistant reported that the patient was administered the doses of Havrix and infanrix vaccines after a temperature excursion in the right arm. The reporter consented to follow-up. Additional supportive information: The patient was administered the doses of Havrix and infanrix vaccines after a temperature excursion, which led to Incorrect storage of drug. This is one of 11 cases, reported by the same reporter. The case US2022093643 was identified as duplicate of this case. The case US2022093643 was deleted and all future correspondence would be added in the present case which stands as case of record for this patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022093643:Same reporter US-GLAXOSMITHKLINE-US2022093600:Same reporter. US-GLAXOSMITHKLINE-US2022093602:Same reporter. US-GLAXOSMITHKLINE-US2022093637:Same reporter. US-GLAXOSMITHKLINE-US2022093638:Same reporter. US-GLAXOSMITHKLINE-US2022093640:Same reporter. US-GLAXOSMITHKLINE-US2022093642:Same reporter. US-GLAXOSMITHKLINE-US2022093644:Same reporter. US-GLAXOSMITHKLINE-US2022093645:Same reporter. US-GLAXOSMITHKLINE-US2022093646:Same reporter. US-GLAXOSMITHKLINE-US2022093647:Same reporter. US-GLAXOSMITHKLINE-US2022093648:Same reporter.
p/vax swelling initially noted around inj site on afternoon of 10/21/99 spread to wrist;erythema to the elbow devel as well as erythema;6x7cm induration;cellulitis;
A consumer reported the occurrence of congestion in a 44 year old adult male who was vaccinated with hepatitis B recombinant vaccine (Engerix-B) for prophylaxis.  This report was received from the subject's wife and has not been confirmed by a physician or any other health care professional.  The subject did not have any relevant medical history or concurrent conditions.  Concurrent medications were unspecified.  On 10/07/2002, the subject received the third injection of hepatitis B vaccine recombinant (LOT # ENG5207A2) three days past the labeled expiration date.  The subject's wife reported that the injection was a "pediatric vaccine" and "may not have gotten the recommended dose." However, in follow up it was reported that the subject received the adult injection 20mcg/1.0ml.  Additionally, on this date, the subject experienced soreness at the injection site, "more than with previous shots" which resolved.  At the end of 2002, the subject's wife reported that the subject developed congestion and coughing.  On an unspecified date, the subject was seen by his health care provider and prescribed antibiotic therapy (name and dosage unspecified).  The reporter stated that the congestion and coughing had improved.
Patient had loose stools while in bathroom with caregiver and very anxious. Patient given snacks and water and released to family. 114/65, 82, 16, 98% RA
The day after the injection ( January 8) I had a very sore left arm, fever, chills, fatigue, muscle aches.  During the next week I had occasional fever and chills , fatigue and muscle aches.   On January 14, my  upper left arm began itching and swelling.  This has continued including the entire upper arm becoming very hot to the touch.  It has subsided somewhat by January 17.  Should I get the second dose scheduled for Feb 4?
Pt is fully vaxed for moderna and went to get a flu shot and was given a pfizer shot
Had a fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Had a fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Had a fever). At the time of the report, PYREXIA (Had a fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not reported. Treatment information was not provided.
Itchy rash; Rash under her bra line flat dots some are big and some are small/rash on legs/rash on stomach area; Red circle at the injection site; Left arm became swollen; Left arm became warm; COVID arm; Left arm gradually turned pink; Left arm itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Left arm itchy), PERIPHERAL SWELLING (Left arm became swollen), SKIN WARM (Left arm became warm), VACCINATION SITE REACTION (COVID arm) and ERYTHEMA (Left arm gradually turned pink) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On 19-Jan-2021, the patient experienced PRURITUS (Left arm itchy). On 20-Jan-2021, the patient experienced PERIPHERAL SWELLING (Left arm became swollen), SKIN WARM (Left arm became warm), VACCINATION SITE REACTION (COVID arm), ERYTHEMA (Left arm gradually turned pink) and VACCINATION SITE ERYTHEMA (Red circle at the injection site). On an unknown date, the patient experienced RASH PRURITIC (Itchy rash) and RASH (Rash under her bra line flat dots some are big and some are small/rash on legs/rash on stomach area). On 23-Jan-2021, PRURITUS (Left arm itchy), PERIPHERAL SWELLING (Left arm became swollen), SKIN WARM (Left arm became warm), VACCINATION SITE REACTION (COVID arm), ERYTHEMA (Left arm gradually turned pink) and VACCINATION SITE ERYTHEMA (Red circle at the injection site) had resolved. At the time of the report, RASH PRURITIC (Itchy rash) and RASH (Rash under her bra line flat dots some are big and some are small/rash on legs/rash on stomach area) outcome was unknown.            Products known to have been used by the patient, within two weeks prior to the event, included unknown cholesterol medication.  Treatment for the event included lubriderm, acetaminophen and maximum strength topical cortisone.   This case was linked to MOD-2021-057241 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Feb-2021: NNI.
- Transcribed note from Doctor  History and exam today suggestive of supraspinatus pathology with possible associated mild impingement.  Possible articular vs subacromial injection given proximity to these structures, although unlikely given angle of injection.  Prescribed short course of NSAID for reduction of inflammation as well as Voltaren for pain not controlled by oral medication.  Continue heat/ice as needed for pain control.  Given HEP for shoulder mobility.   RTC for referral to formal PT if no improvement over next 3-4 days.  Given close return precautions and ER precautions for signs of infected joint.
She completed vaccines in January, 2021. She fell at the local assisted living facility and complained back pain, and she was sent to the emergency department at Hospital on 9/28/21. She also complained dizziness since 9/24/21 after she was given  Flu shot, but no details of vaccine was given by the facility. She complained intermittent shortness of breath, and COVID was positive. She was admitted on 9/28/21. She was given one dose of Remdesivir, but she remained afebrile during her hospitalization. She was discharged to the skilled nursing facility  on 10/5/21. At one point, she was required 3 L O2, but she did not need oxygen supplemental O2 upon discharge from hospital.
This spontaneous case was reported by an other health care professional and describes the occurrence of PHANTOM LIMB SYNDROME (terrible phantom pain/Extreme phantom pain caused by vaccination 2 and boostet), MUSCLE SPASMS (muscle spasm) and PROCTALGIA (anal pain) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069F21A, 001A21A and 013F20A) for COVID-19 vaccination. The patient's past medical history included Leg amputation in July 2020, Heart attack (heart attack during procedure which followed by getting Stent), COVID-19 (covid + during his stay in nursing home in summer of 2020) in 2020 and Stent placement. Concurrent medical conditions included Drug allergy (Norco Allergy). On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PHANTOM LIMB SYNDROME (terrible phantom pain/Extreme phantom pain caused by vaccination 2 and boostet), MUSCLE SPASMS (muscle spasm) and PROCTALGIA (anal pain). At the time of the report, PHANTOM LIMB SYNDROME (terrible phantom pain/Extreme phantom pain caused by vaccination 2 and boostet), MUSCLE SPASMS (muscle spasm) and PROCTALGIA (anal pain) outcome was unknown. No Concomitant Medications were provided by the reporter. No Treatment Information were provided by the reporter. This case was linked to MOD-2021-411001, MOD-2021-076510 (Patient Link).Most recent FOLLOW-UP information incorporated above includes: On 14-Dec-2021: Follow up received contains Report type changed from Consumer to Other Health Professional.
felt horrible; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 72 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "recovering", described as "felt horrible".  No follow-up attempts were possible. No further information was expected.  Additional information: While on call with patient stated that the patient had to stop taking Xeljanz for 10days after receiving the COVID vaccine. The patient stated that she felt horrible, and started to feel better now she's been back on Xeljanz for two days.
Acute migraines. Started off as facial pain. Primary doctor prescribed antibiotics and steroids and nothing worked. Wound up in an Emergency Room with terrible dizziness, lightheadedness, and severe head pain rated 10/10 the worst in my life. Diagnosed with migraines and told to follow up with a neurologist. Followed up with neurologist. These migraines only came about 3 weeks after receiving my first dose. I have taken 3 migraine medications and finally found what works for me and have gotten on a good medication regimen. I am in excellent shape, have zero comorbidities, and received this vaccine as mandatory to work in the hospital. I am fresh out of nursing school and now am being declined an exemption for a booster after everything I have been through. I am only now submitting a VAERs form because I have finally figured out what this has attributed to and have sought out the correct treatment.
I had mild symptoms -- just tiredness and sore arm for a few hours following vaccination.  I did not get COVID until 6 months after this dose....  I was very sick for 2 days -- cough, head ache, aching muscles, chills.  Day 3 was very tired and cough remained for 7-10 days getting gradually better each day.
Information has been received from a physician concerning a patient of unspecified age and gender. There was no information about the patient's medical history, concurrent conditions or concomitant medications reported. On 10-JAN-2017, the patient was vaccinated with an expired dose of VAQTA, concentration: 50/1.0 U/ml, lot number: L048222 with expiration date: 19-DEC-2016 (dose was not provided) administered intramuscularly for prophylaxis.  No adverse effects were reported.  There was no product quality complaint involved. Additional information has been requested.
Patient got extremely light-headed, pale and sweaty, blood pressure was 100/78 initially and did normalize to 110/68 5 minutes later. Patient drank water and had some orange juice and remained in the pharmacy for approx 30 mins until he felt better. He did have a companion with him and did not leave alone
Patient received booster dose of Moderna, was in waiting area, tried to stand up and fainted/nearly fainted.  Caught by staff member who was letting him leave after his observation period.  Immediately gained consciousness, assisted to room for 30 minute observation.  No further difficulty.  Recent issues with dizziness/lightheadedness not related to vaccine.
right away she felt pain in neck; bagging in both eyes for about  a week; Left arm hurting now for almost a month; Left eye hurts but the pain went away in a few days/both eyes hurt; headaches; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (right away she felt pain in neck), PERIORBITAL SWELLING (bagging in both eyes for about  a week), PAIN IN EXTREMITY (Left arm hurting now for almost a month), EYE PAIN (Left eye hurts but the pain went away in a few days/both eyes hurt) and HEADACHE (headaches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048F21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN for an unknown indication.    On 05-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (right away she felt pain in neck), PERIORBITAL SWELLING (bagging in both eyes for about  a week), PAIN IN EXTREMITY (Left arm hurting now for almost a month), EYE PAIN (Left eye hurts but the pain went away in a few days/both eyes hurt) and HEADACHE (headaches). At the time of the report, NECK PAIN (right away she felt pain in neck), PERIORBITAL SWELLING (bagging in both eyes for about  a week), PAIN IN EXTREMITY (Left arm hurting now for almost a month) and HEADACHE (headaches) outcome was unknown and EYE PAIN (Left eye hurts but the pain went away in a few days/both eyes hurt) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.  It was reported that the patient experienced that her eyes felt better without the glasses and she was not sure if it was because of vaccine.
Pain in left arm, soreness lasting ~48h tiredness lasting ~48h  Pain in left wrist, inflamed wrist joints, warm to touch, lasting 72h  Joints popping though-out body (both sides): wrists, elbows, hips, ankles, jaw - not resolved until chondroitin supplement started  7 days later Rash on lower back and left ankle appearing 10-14 days later
Patient report that 10 minutes after she receive the vaccination she developed a rash. Later that evening she complained of fever and sweats. She presented at pharmacy today (7 days after vaccination) and showed us circular rashes (itchy) on bilateral arms and bilateral legs.
I did get sick that evening - I had a fever and chills. I did throw up. That lasted all night. The fever broke by the morning. But the exhausted next day - I went home from work early that day. Friday, I got a rash  - very itchy and sore  (it felt very tender when touched)- on my left side (abdomen). It spread around the left side on my back and to my stomach. I say my doctor on this Tuesday (virtual appt) said it was Shingles - Valtrex - to help it heal faster. The rash is starting to scab over and is peeling now.  It's getting better.
Very little arm soreness; Sinus infection; Can hardly walk; Arthritis worse; Dizziness; Fibromyalgia got worse; Felt dazed; Body ache; Nausea; Vomiting; joint pain; headache; Chills; Muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Very little arm soreness), SINUSITIS (Sinus infection), GAIT DISTURBANCE (Can hardly walk), ARTHRITIS (Arthritis worse) and DIZZINESS (Dizziness) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (Very little arm soreness), SINUSITIS (Sinus infection), GAIT DISTURBANCE (Can hardly walk), ARTHRITIS (Arthritis worse), DIZZINESS (Dizziness), FIBROMYALGIA (Fibromyalgia got worse), FEELING ABNORMAL (Felt dazed), PAIN (Body ache), NAUSEA (Nausea), VOMITING (Vomiting), ARTHRALGIA (joint pain), HEADACHE (headache), CHILLS (Chills) and MYALGIA (Muscle pain). At the time of the report, PAIN IN EXTREMITY (Very little arm soreness), SINUSITIS (Sinus infection), GAIT DISTURBANCE (Can hardly walk), ARTHRITIS (Arthritis worse), DIZZINESS (Dizziness), FIBROMYALGIA (Fibromyalgia got worse), FEELING ABNORMAL (Felt dazed), PAIN (Body ache), NAUSEA (Nausea), VOMITING (Vomiting), ARTHRALGIA (joint pain), HEADACHE (headache), CHILLS (Chills) and MYALGIA (Muscle pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment details included antibiotics for sinus infection.
flushed tachycardia; numb lips; chest pain; shortness of breath; chills; aches; This is a spontaneous report from a contactable nurse. The 34-Year old female patient received bnt162b2 (BNT162B2, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 14Jan2021 (Batch/Lot Number: El3246) as SINGLE DOSE for covid-19 immunisation. Medical history included asthma and seasonal allergy from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On 18Jan2021 the patient experienced 5 minutes after injection, flushed tachycardia and numb lips. 3 days later chest pain, shortness of breath, tachycardia, chills, aches. Covid negative. Still not fully resolved. The patient underwent lab tests and procedures which included viral test: negative on 20Jan2021. The action taken in response to the events for bnt162b2 was not applicable. The outcome of the events was reported as not recovered.
edema & erythema @ inject site plus tenderness, devel w/in 24 hr of injection & present today. SX are diminishing according to pt.
Information has been received from a certified medical assistant concerning a female patient with a penicillin allergy who on 09-JAN-2007, was vaccinated with a dose of Gardasil. On 16-JUL-2007, the patient experienced tachycardia and was hospitalized. On 20-JUL-2007, it was reported that the patient was released from the hospital. On an unspecified date, the patient recovered. No product quality complaint was involved. The reporter considered tachycardia to be life threatening and an other important medical event. Additional information is not expected.
chills and fever 4/10/21 hives began 4/11/21 along with moderate SOB and chest tightness. patient used her albuterol inhaler, took 2 doses of benadryl and reports she is much better today.